Topiramate
Product Images NDC 53217-329

4 FDA label images from Aidarex Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 53217-329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi (Topiramate 100mg 1)

Topi (Topiramate 100mg 1)
Chemical structure diagram of topiramate, showing its molecular arrangement including several oxygen atoms, methyl groups, and a sulfonamide group.*
FDA Label Image

Topi (Topiramate 100mg 2)

Topi (Topiramate 100mg 2)
A Kaplan-Meier curve showing cumulative rates over time. The y-axis represents cumulative rates for time to an event, ranging from 0.00 to above 0.30. The x-axis indicates time in days, spanning from 0 to approximately 450. Two curves are displayed: a solid line with steeper increase and a dashed line with slower increase, indicating a significant difference (p = 0.0002).*
FDA Label Image

Figure 2: Reduction In 4-week Migraine Headache Frequency (studies 10 And 11 For Adults And Adolescents) (Topiramate 100mg 3)

Figure 2: Reduction In 4-week Migraine Headache Frequency (studies 10 And 11 For Adults And Adolescents) (Topiramate 100mg 3)
A bar chart comparing the change from baseline to double-blind phase in average weekly migraine period rate in two studies for Placebo and Topamax at doses of 50 mg/day, 100 mg/day, and 200 mg/day. The chart shows bars representing Study 10 and Study 11 with statistically significant reductions for Topamax at 100 mg/day and 200 mg/day doses.*
FDA Label Image

53217-0329_topiramate_100mg (Topiramate 100mg 4)

53217-0329_topiramate_100mg (Topiramate 100mg 4)
Topiramate USP 100 mg oral tablet label from Aidarex Pharmaceuticals LLC. The label indicates a quantity of 60 film-coated tablets with each tablet containing 100 mg of topiramate. It includes the NDC number 53217-0329-60 and mentions packaging by Aidarex Pharmaceuticals. Additional manufacturer information shows CIPL Ltd. India with an INS code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.